3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
1
Sarcoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma
1
Liposarcoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyosarcoma
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hemangiosarcoma
1
Dermatofibrosarcoma
1
Interventions
Rituximab
40
Cyclophosphamide
29
Etoposide
15
Doxorubicin
14
Vincristine
13
Prednisone
13
ibrutinib
10
fludarabine
10
fludarabine phosphate
8
Cytarabine
8
Mycophenolic Acid
7
Bortezomib
7
Lenalidomide
6
Carmustine
6
pembrolizumab
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Inotuzumab Ozogamicin
5
Whole-Body Irradiation
4
Tacrolimus
4
Carboplatin
4
CT-P10
4
Brentuximab Vedotin
4
Antilymphocyte Serum
4
tositumomab I-131
3
tocilizumab
3
tazemetostat
3
obinutuzumab
3
idelalisib
3
etoposide phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, B-Cell
×
TTI-621
×
Clear all
No trials found.